Analysis of the Correlation Between Peripheral Blood Lymphocyte Subsets and Pathological Complete Response Rate in Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy
Technology in Cancer Research & Treatment · 2026-08 · 25
DOI: 10.1177/15330338261500554 ↗Abstract
Introduction Locally advanced rectal cancer receives neoadjuvant chemoradiotherapy (nCRT) as standard clinical management. Reliable non-invasive biomarkers for predicting pathological complete response (pCR) after nCRT remain urgently needed. This study aimed to explore correlations between peripheral blood lymphocyte subsets and pCR rate in rectal cancer patients receiving nCRT, and screen predictive immune markers for individualized therapeutic decision-making. Methods This was a retrospective cohort study. A total of 143 rectal cancer patients receiving nCRT in our center between June 2021 and December 2022 were consecutively enrolled. Tumor regression grade (TRG) was applied to evaluate pathological treatment response. Kolmogorov–Smirnov test, Mann–Whitney U test, chi-squared test, binary logistic regression and ROC curve analyses were performed to investigate associations between lymphocyte subsets and pCR. Results A total of 48 patients (33.6%) achieved pCR after nCRT. Absolute counts of all detected peripheral blood lymphocytes after nCRT. Gender and age were correlated with lymphocyte subsets: males had higher absolute counts and percentages of NK cells than females (P
EUVIMED